Patent application number | Description | Published |
20080317905 | Methods for Promoting Health or Wellness in Adult Animals - Methods for promoting health or wellness, regulating food intake, and increasing nitrogen retention in an adult animal by feeding the animal a food containing lysine in an amount of at least about 3% by weight of total protein. Also, kits containing lysine and a food suitable for consumption in separate packages and instructions for how to combine the lysine and food are provided. | 12-25-2008 |
20090028996 | METHODS FOR REDUCING FOOD INTAKE AND CONTROLLING THE WEIGHT OF ANIMALS - Methods for reducing food intake by and controlling the weight of an animal by feeding the animal a composition comprising a food intake reducing amount or a weight controlling amount of a soluble fiber. | 01-29-2009 |
20090123951 | Method Of Diagnosing A Body Weight Condition Or Predisposition - A method for diagnosing a body weight condition or predisposition to a body weight condition in an animal by determining observed level(s) of at least one biomarker in a tissue or biofluid sample from the animal and comparing the observed level(s) to reference level(s) for the biomarker; wherein the observed level(s) relative to the reference level(s) are individually or collectively indicative of the body weight condition or predisposition. | 05-14-2009 |
20090253791 | Compositions and Methods For Preventing Or Treating Inflammatory Bowel Disease - Compositions comprising docosahexaenoic acid (DHA) and optionally one or more fatty acids selected from the group consisting of eicosapentaenoic acid (EPA), arachidonic acid (ARA), linoleic acid (LA), and α-linoleic acid (ALA) are administered to felines for preventing or treating feline inflammatory bowel disease (IBD). | 10-08-2009 |
20090263855 | Compositions and Methods For Preventing or Treating Inflammatory Bowel Disease - Compositions comprising docosahexaenoic acid (DHA) and optionally one or more fatty acids selected from the group consisting of eicosapentaenoic acid (EPA), arachidonic acid (ARA), linoleic acid (LA), and α-linoleic acid (ALA) are administered to felines for preventing or treating feline inflammatory bowel disease (IBD). | 10-22-2009 |
20100261793 | METHOD FOR DECREASING CARTILAGE DAMAGE IN DOGS - A method for modulating enzymatic degradation of articular cartilage in a dog comprises administering to the dog an enzymatic degradation modulating effective amount of eicosapentaenoic acid (EPA), for example as a component of a food composition. By practice of the method in a dog having arthritis, mobility of the dog can be increased, weight bearing in an arthritic limb can be increased, and/or pain associated with arthritis can be reduced. | 10-14-2010 |
20100323908 | Methods and Compositions For Diagnosing Osteoarthritis In A Feline - Methods, compositions and kits for diagnosing osteoarthritis in a feline are disclosed. The methods of the invention comprise detecting differential expression of at least one biomarker in a body sample. preferably a blood sample, where the biomarker is differentially expressed in osteoarthritis. | 12-23-2010 |
20110081443 | HIGH PROTEIN, LOW CARBOHYDRATE FOOD COMPOSITION HAVING NON-FERMENTABLE FIBER - A food composition is provided having high protein levels, high fat levels, low carbohydrate levels and non-fermentable fiber. Methods of using these compositions for weight management in mammals are also provided. | 04-07-2011 |
20120142009 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE - Compositions comprising docosahexaenoic acid (DHA) and optionally one or more fatty acids selected from the group consisting of eicosapentaenoic acid (EPA), arachidonic acid (ARA), linoleic acid (LA), and α-linoleic acid (ALA) are administered to felines for preventing or treating feline inflammatory bowel disease (IBD). | 06-07-2012 |
20140179552 | METHODS AND COMPOSITIONS FOR DIAGNOSING OSTEOARTHRITIS IN A FELINE - Methods, compositions and kits for diagnosing osteoarthritis in a feline are disclosed. The methods of the invention comprise detecting differential expression of at least one biomarker in a body sample, preferably a blood sample, where the biomarker is differentially expressed in osteoarthritis. | 06-26-2014 |